The Nebraska State Racing Commission has served hearing notices to seven trainers of horses whose post-race samples tested positive for clonidine, a drug used in humans to treat high blood pressure. The commission released the names of the trainers Thursday as a matter of public record.
A human drug used to treat high blood pressure, Attention Deficit Hyperactivity Disorder, and addictive behavior has been detected in at least 10 post-race samples of horses racing in Nebraska recently, and sources say the number of positive tests could double in the coming weeks. Seven trainers have been notified by the Nebraska Racing Commission that their horses tested positive for Clonidine, which drug testing experts say can have both a calming and analgesic effect on horses and is closely related to Romifidine and Guanabenz, two drugs suspected by racing officials as being used illegally on horses.
Most Popular Stories
- Final Call for Taylors of Seattle Slew Fame
- NY Investigation of Asmussen Case Completed
- NYRA Unveils 10-Race Claiming Series
- New York Sanctions Mott for Drug Overages
- National HBPA Sets Convention Agenda
- Racing Investigators to Meet in NJ in March
- 'Chrome' Set for San Antonio, Bayern Doubtful
- Main Sequence Works at Palm Meadows
- TCA to Present Awards of Merit
- 74-Year-Old Horseplayer Wins 2015 NHC Title